Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Compass Therapeutics (NASDAQ:CMPX) through any online brokerage.
Other companies in Compass Therapeutics’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), CytomX Therapeutics (NASDAQ:CTMX), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT) and Replimune Group (NASDAQ:REPL).
Compass Therapeutics has a consensus price target of $11.94.
The stock price for Compass Therapeutics (NASDAQ: CMPX) is $4.83 last updated November 14, 2025 at 4:00 PM EST.
There are no upcoming dividends for Compass Therapeutics.
Compass Therapeutics’s Q3 earnings are confirmed for Wednesday, November 5, 2025.
There is no upcoming split for Compass Therapeutics.
Compass Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.